Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age.

Hoffman K, Webster TF, Weisskopf MG, Weinberg J, Vieira VM.

Environ Health Perspect. 2010 Dec;118(12):1762-7. doi: 10.1289/ehp.1001898. Epub 2010 Jun 15.

2.
3.

Perfluoroalkyl chemicals and asthma among children 12-19 years of age: NHANES (1999-2008).

Humblet O, Diaz-Ramirez LG, Balmes JR, Pinney SM, Hiatt RA.

Environ Health Perspect. 2014 Oct;122(10):1129-33. doi: 10.1289/ehp.1306606. Epub 2014 Jun 6.

4.

Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age.

Stein CR, Savitz DA.

Environ Health Perspect. 2011 Oct;119(10):1466-71. doi: 10.1289/ehp.1003538. Epub 2011 Jun 10.

5.

Fetal exposure to perfluorinated compounds and attention deficit hyperactivity disorder in childhood.

Ode A, Källén K, Gustafsson P, Rylander L, Jönsson BA, Olofsson P, Ivarsson SA, Lindh CH, Rignell-Hydbom A.

PLoS One. 2014 Apr 23;9(4):e95891. doi: 10.1371/journal.pone.0095891. eCollection 2014.

6.

Association between serum perfluorinated chemicals and thyroid function in U.S. adults: the National Health and Nutrition Examination Survey 2007-2010.

Wen LL, Lin LY, Su TC, Chen PC, Lin CY.

J Clin Endocrinol Metab. 2013 Sep;98(9):E1456-64. doi: 10.1210/jc.2013-1282. Epub 2013 Jul 17.

PMID:
23864701
7.

Cross-sectional association between polyfluoroalkyl chemicals and cognitive limitation in the National Health and Nutrition Examination Survey.

Power MC, Webster TF, Baccarelli AA, Weisskopf MG.

Neuroepidemiology. 2013;40(2):125-32. doi: 10.1159/000342310. Epub 2012 Oct 24.

8.

Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population.

Nelson JW, Hatch EE, Webster TF.

Environ Health Perspect. 2010 Feb;118(2):197-202. doi: 10.1289/ehp.0901165.

9.
10.

Do perfluoroalkyl substances affect metabolic function and plasma lipids?--Analysis of the 2007-2009, Canadian Health Measures Survey (CHMS) Cycle 1.

Fisher M, Arbuckle TE, Wade M, Haines DA.

Environ Res. 2013 Feb;121:95-103. doi: 10.1016/j.envres.2012.11.006. Epub 2012 Dec 22. Erratum in: Environ Res. 2013 Oct;126:221.

PMID:
23266098
11.

Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls.

Maisonet M, Terrell ML, McGeehin MA, Christensen KY, Holmes A, Calafat AM, Marcus M.

Environ Health Perspect. 2012 Oct;120(10):1432-7. doi: 10.1289/ehp.1003096. Epub 2012 Aug 30.

12.

Polyfluoroalkyl chemicals and menopause among women 20-65 years of age (NHANES).

Taylor KW, Hoffman K, Thayer KA, Daniels JL.

Environ Health Perspect. 2014 Feb;122(2):145-50. doi: 10.1289/ehp.1306707. Epub 2013 Nov 26.

13.

Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey.

Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS.

Environ Health Perspect. 2010 May;118(5):686-92. doi: 10.1289/ehp.0901584. Epub 2010 Jan 7.

14.

Association between perfluoroalkyl acids and kidney function in a cross-sectional study of adolescents.

Kataria A, Trachtman H, Malaga-Dieguez L, Trasande L.

Environ Health. 2015 Nov 21;14:89. doi: 10.1186/s12940-015-0077-9.

15.

Polyfluoroalkyl compounds in Texas children from birth through 12 years of age.

Schecter A, Malik-Bass N, Calafat AM, Kato K, Colacino JA, Gent TL, Hynan LS, Harris TR, Malla S, Birnbaum L.

Environ Health Perspect. 2012 Apr;120(4):590-4. doi: 10.1289/ehp.1104325. Epub 2011 Dec 19.

16.

Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.

Khalil N, Chen A, Lee M, Czerwinski SA, Ebert JR, DeWitt JC, Kannan K.

Environ Health Perspect. 2016 Jan;124(1):81-7. doi: 10.1289/ehp.1307909. Epub 2015 Jun 9.

17.

Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.

Liew Z, Ritz B, von Ehrenstein OS, Bech BH, Nohr EA, Fei C, Bossi R, Henriksen TB, Bonefeld-Jørgensen EC, Olsen J.

Environ Health Perspect. 2015 Apr;123(4):367-73. doi: 10.1289/ehp.1408412. Epub 2014 Dec 19.

18.

Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008.

Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM.

Environ Sci Technol. 2011 Oct 1;45(19):8037-45. doi: 10.1021/es1043613. Epub 2011 Apr 6.

PMID:
21469664
19.

Perfluoroalkyl substances and time to pregnancy in couples from Greenland, Poland and Ukraine.

Jørgensen KT, Specht IO, Lenters V, Bach CC, Rylander L, Jönsson BA, Lindh CH, Giwercman A, Heederik D, Toft G, Bonde JP.

Environ Health. 2014 Dec 22;13:116. doi: 10.1186/1476-069X-13-116.

20.

Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003-2011.

Okada E, Kashino I, Matsuura H, Sasaki S, Miyashita C, Yamamoto J, Ikeno T, Ito YM, Matsumura T, Tamakoshi A, Kishi R.

Environ Int. 2013 Oct;60:89-96. doi: 10.1016/j.envint.2013.07.013. Epub 2013 Sep 6.

PMID:
24013022

Supplemental Content

Support Center